Xero's CEO is all about AI these days, but says that cheap tools can't easily replicate its platform. So I built one myself to test...
Yesterday we saw the announcement nobody wanted: a rate rise from the RBA. It was the first rate increase since November 2023, and followed three...
While being the country’s Treasurer is a tough job, the buck stops with the politician in charge of keeping this country’s books in good order.
Let’s check out how many ‘experts’ think that the RBA will raise the interest rate curtain.
The time has come for me to make my 2026 predictions, and I have decided to do it in two parts.
Australia’s corporate regulator has secured refunds of A$40 million to more than 38,000 investors in risky financial products, following a review of the industry.
I’m taking the long-term punt on these three quality plays that have been beaten up big time of late
In this article, we look at how our model portfolios have performed so far in 2026.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.
Here are three more stocks that look to be good buying opportunities at current prices.
The price of copper and gold have been boosted by bullish short-term sentiment, but as always I believe investors should also continue to take a…
For the week ending Friday, January 30, 2026, FNArena tracked twenty-four upgrades and twenty-six downgrades for ASX-listed companies from brokers monitored daily.